Transcription and DNA damage: a link to a kink. by Scicchitano, D A & Mellon, I
Transcription and DNA Damage:
A Link to a Kink
David A. Scicchitanol and Isabel Mellon2
1Department of Biology, New York University, New York, NewYork;
2Department of Pathology, Markey Cancer Center,
University of Kentucky, Lexington, Kentucky
Living organisms are constantly exposed to a variety of naturally occurring and man-made
chemical and physical agents that pose threats to health by causing cancer and other illnesses, as
well as cell death. One mechanism by which these moieties can exert their toxic effects is by
inducing modifications to the genome. Such changes in DNA often result in the formation of
nucleotides not normally found in the double helix, bases containing covalent chemical
alterations, single- and double-strand breaks, and interstrand and intrastrand cross-links. When
these lesions are present during replication, mutations often result in the newly synthesized
DNA. Likewise, when such damage occurs in a gene, transcription elongation, and hence
expression, can be adversely affected because of pausing or arresting of the RNA polymerase at
or near the altered site; this could result in the synthesis of a defective RNA molecule. It has
become increasingly clear that transcription and DNA damage are intimately linked, since the
removal of certain adducts from the genome is highly dependent on their location: When such
lesions are present on the transcribed strand of actively expressed genetic loci, they are better
cleared from that strand when compared to the complementary DNA or other quiescent regions.
This process is called transcription-coupled DNA repair, and it modulates the mutagenic spectrum
of many DNA-damaging agents. Furthermore, based upon evidence from systems in which it is
absent, this process has a profound effect on ameliorating the adverse consequences of
exposure to many environmentally relevant genotoxins. The precise cellular pathway that
mediates the preferential clearance of DNA damage from active genetic loci has not yet been
established, but it appears to be effected by a repertoire of proteins that are also involved in other
DNA repair pathways and transcription as well as some factors that might be unique to it.
Because a cellular process as indispensable as gene expression can be thwarted by the presence
of DNA damage, an understanding of the mechanism underlying transcription-coupled DNA repair
is relevant to the continued discernment of how environmental genotoxins endanger human
health. - Environ Health Perspect 105(Suppl 1):145-1 53 (1997)
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Introduction
Many hazardous environmental agents exert by these genotoxins consists ofsingle- and
their toxic effects on humans and other double-strand breaks, modified bases and
organisms by inducing modifications to the phosphate groups, and interstrand and
genome; included among these agents are intrastrand cross-links, among others (1,2).
numerous natural and man-made chemical When these alterations remain in the
compounds as well as several types of double helix, replication can be blocked or
radiation. The damage produced in DNA impeded, mutations to the genome can
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result when replication does occur, and
gene expression can be compromised due
to improper transcription, potentially lead-
ing to cellular transformation or death
(2,3). It is critical that such damage be
removed to ensure fidelity during DNA
synthesis and to enable the cell to continue
appropriate RNA synthesis.
Broadly defined, DNA repair refers to
the collected pathways in a cell that assist
in maintaining genomic integrity by
removing inappropriate bases and other
possible deleterious lesions from DNA.
Numerous mechanisms have evolved to this
end: a) nucleotide excision repair (NER)
(2,4-6), b) base excision repair (BER)
(2,7,8), c) mismatch repair (MMR) (2,9),
and d) direct reversal of the damage, in
which no incision is made in the backbone
of the DNA (2,10,11). Overlap among
these pathways exists in terms ofthe types of
damage removed by each.
An important component ofthe DNA
repair process that is involved in clearing
the genome of damage is transcription-
coupled DNA repair (TCR). This phenom-
enon is characterized by more rapid
removal ofcertain modified bases from the
transcribed strand of actively expressed
genes when compared to silent DNA
(3,12,13). It has been proposed that TCR
might exist to ensure that transcription can
readily continue following a genotoxic
assault, thus providing a means for produc-
ing transcripts essential for continued cell
survival (3). A corollary to this notion is
that lesions in DNA that block or inhibit
the progression of RNA polymerases are
precisely those that are subject to TCR
(3,13). Hence, the process oftranscription
is linked to DNA damage in that it can
influence the clearance rate ofcertain lesions
formed in the genome following exposure to
manyenvironmentally relevant genotoxins.
Several questions lie at the heart ofcur-
rent studies designed to understand TCR:
a) What lesions are subject to it? b) How
do such alterations to DNA impede or
block the progression ofRNApolymerases?
c) What is the actual mechanism by which
preferential clearance of DNA adducts is
achieved, and d) which organisms exhibit
the phenomenon? The first question
concerns the classes of DNA damage that
are cleared preferentially from actively
expressed genetic domains and is addressed
in Table 1. This article will focus more on
issues b and c-the matter of DNA
damage posing blocks to transcription and
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Table 1. Genotoxic agents and their relationships to
TCR.
Genotoxic agents
producing DNAdamage Selected referencesa
SubjecttoTCR
UV Radiation (14-16)
Benzo[a]pyrene 117)b
Benzo[c]phenanthrene (18)
N-Ethyl-N-nitrososurea (Sitaram et al.,
unpublished
observations)
CC-1065 (19)
Aflatoxin B1 (20)
Cisplatin (21)
Oxidizing agents/
ionizing radiation (22)
Psoralen interstrand (23,24)
DNAcross-links
NotsubjecttoTCR
Dimethyl sulfate (25)
Methyl methanesulfonate (26)
N-Methyl-N-nitrosourea (26)
N-Methyl-N'-nitro- (26)
N-nitrosoguanidine
Aminofluorene (27)
Psoralen monoadducts (24)
Benzo[a]pyrene (28)b
'For a more complete list of references concerning
TCR of DNA adducts, see Friedberg et al. (2).
bBenzo[alpyrene has been reported to produce damage
that is subject to TCR in one case but not cleared by
this pathway in another. Importantly, the investigators
used different cell lines and different genetic loci in
each, indicating that TCR of DNA damage is a function
ofcell type and the target locus.
the mechanism ofTCR. Transcription-
coupled DNA repair in mammalian
systems will be emphasized, with studies
concerning this type ofrepair in Escherichia
coli being described because ofthe attrib-
utes ofthis organism that make it a useful
model for understanding the process.
Spatial constraints do not permit descrip-
tions ofTCR in yeast and other impor-
tant systems; information concerning the
process in these organisms can be found in
several current texts and reviews (2,29).
Also, the involvement of DNA repair dur-
ing organismal development, an important
issue due to the high levels ofreplication
and transcription during maturation, will
not be addressed (30).
Neither the precise series ofevents nor
all of the proteins required during TCR
have been fully elucidated; however, recent
studies suggest that components ofseveral
DNA repair pathways are involved, with
the presence ofadditional factors being nec-
essary to link transcription to the removal
ofdamage from active genes. Therefore,
better understanding of TCR can be
achieved by considering the involvement of
individual repair pathways and coupling
factors in the process. To that end, a sum-
mary ofwhat is known about the effect of
modified bases in DNA on pausing and
arresting RNA polymerases during tran-
scription elongation will be undertaken;
this will be followed by briefdiscussions of
individual DNA repair pathways, with
each section containing a description of
what is known about that particular path-
way's relationship to TCR. Finally, a
model describing a potential mechanism
for TCRwill be presented.
Transcription and
DNA Damage
GeneExpression andTranscription-
coupledDNARepair
An important question concerning TCR
now needs to be considered: Is transcrip-
tion actually necessary for TCR of an
adduct, or is the mere presence ofa lesion
in the transcribed strand of a gene suffi-
cient for its preferential removal from the
region? Studies evaluating TCR in E. coli
have made use ofthe lac operon as a target
locus to address this issue. Following expo-
sure to ultraviolet (UV) light, cyclobutane
pyrimidine dimers (CPDs) were removed
from the transcribed and nontranscribed
strands of the uninduced lacZ gene at
virtually identical rates, with 50% of the
adducts being cleared in 20 min. When
an identical experiment was performed
using E. coli previously exposed to an
agent that induces the lacoperon, the rate
of repair in the transcribed strand of the
lacZ gene rose approximately 10-fold,
such that it was cleared of 50% of the
damage in about 2 min; repair in the non-
transcribed strand remained the same as
that seen in the uninduced state. These
results clearly demonstrate the need for
active gene expression for TCR to occur
in E. coli(31).
For mammalian cells, several pieces of
evidence suggest that active transcription
by RNA polymerase II is needed for TCR.
When cells are exposed to a-amanitin,
a drug that inhibits RNA polymerase
II, TCR of CPDs is abolished (32).
Interestingly though, rRNA genes, which
are transcribed by RNA polymerase I, are
not subject to TCR (33). These data, in
conjunction with those from E. coli, insin-
uate that the rapid repair of lesions from
transcribed DNA requires that the locus in
question be actively transcribed by certain
RNA polymerases and that the region
encodes mRNA.
DNADamage: RNAPolymerase
Pauses andArrests
The notion that TCR is activated by
lesions in DNA that impede transcription
relies on understanding the effect ofDNA
modifications on RNA synthesis. A gene is
comprised ofboth an actual transcription
unit and regulatory regions that assist in
controlling its expression. Theoretically,
damage located at any position within a
gene could impede transcription. A lesion
could cause the polymerase to pause, with
eventual bypass occurring, or pose a block
to its progression, causing it to arrest and
stop elongation. These events could occur
at any of the three basic stages associated
with the process-initiation, elongation,
and termination. Ifan adduct were present
in the regulatory region ofthe gene and it
prevented the formation of an initiation
complex, expression ofthat gene would be
seriously impaired. Similarly, if the adduct
were in the transcription unit and RNA
polymerase progression were to be paused
or arrested, faulty transcripts could result,
jeopardizing vital cellular processes; it is
this situation that has been hypothesized to
provide part of the link between DNA
damage and transcription (3).
Studies concerning the effect ofbase
modifications in DNA on RNA synthesis
by RNA polymerases are much less well
developed than those for DNA polymerase
effects on both processivity and base misin-
corporation. Recently, however, descrip-
tions ofthe behavior of a variety of RNA
polymerases at adducts placed at specific
sites in a DNA template have been
reported. Such a technique has the advan-
tage ofpermitting the investigator to know
the precise nature and position ofthe DNA
modification being examined. Lesions
derived from radiation and chemicals have
been explored in this way, and a summary
ofsome ofthe important findings is essen-
tial for analyzing the role ofblocked tran-
scription in TCR.
Earlyexperiments concerning the ability
ofDNAdamaged by UV radiation to block
transcription were described by Sauerbier
and Hercules (34). Recently, investigations
using thymine.thymine CPDs placed site-
specifically in a DNA template containing
the major late promoter of adenovirus
showed that these lesions are strong blocks
to the progression of rodent RNA poly-
merase II; furthermore, the lesion must be
present on the template strand for the
polymerase to stall. It was also shown that
elongation factor SII (TFIIS) can induce
cleavage ofthe nascent transcript at the site
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of the dimer, but the process does not
enhance the bypass ofthe lesion (35). These
studies are quite significant because they
address the issue ofthe effect oftranscrip-
tion elongation factors on lesion bypass; in
fact, as more such factors are discovered,
consideration oftheir role in RNA synthesis
past DNAadducts will be important.
Studies concerning the bypass ofsite-
specific chemical adducts in DNA have
also been undertaken. Psoralen-dT lesions
present as either a monoadduct or diadduct
efficiently block transcription by T7 RNA
polymerase and E. coli RNA polymerase
(36,37); acetylaminofluorene-dG (AAF-
dG) and aminofluorene-dG (AF-dG)
adducts inhibit transcription by both T7
RNA polymerase and RNA polymerase III
(38,39); and benzo[a]pyrenediol epoxide-
dG (BPDE-dG) lesions impede transcrip-
tion by T7 RNA polymerase (40). It is
important to understand that, unlike CPDs,
many ofthese adducts do not pose absolute
blocks to the progression ofan RNA poly-
merase. For BPDE lesions, the stereochem-
istry of the actual N2-guanine adduct
profoundly affects the ability ofbypass to
occur (40). Hence, ifa stalled RNA poly-
merase complex were a requisite event for
the TCRofan adduct, certain modifications
to DNA could escape this pathway and be
repaired by alternate mechanisms or remain
in the gene. Also, the role ofan elongation
factor such as SII might be increasingly
important for adducts that act as pause sites
rather than arrest signals; of course, the
validity ofthis needs further testing.
Another important aspect oftranscrip-
tional bypass ofDNA adducts is the notion
of base misincorporation in mRNA, an
event that could change the protein
encoded by the transcript; likewise, the
dissociation ofa nascent mRNA at the site
of an adduct results in a truncated tran-
script, an event that would lead to synthe-
sis ofan incomplete protein or possibly no
protein. It is precisely these possibilities
that might form the underlying reason that
preferential clearance oflesions from actively
transcribed DNA exists: TCR supplies a
rapid and efficient means of removing
adducts from active genes, which protects
the innate integrity of the mRNA being
produced (3). Interestingly, though, full-
length transcripts resulting from lesion
bypass ofAF-dG, AAF-dG, and BPDE-dG
lesions by T7 RNA polymerase contain the
correct nucleotide sequence, but truncated
transcripts due to the RNA polymerase
stalling in the presence of BPDE-dG
adducts almost always endwith an incorrect
base (Choi et al., unpublished observa-
tions). Such data suggest that the ability of
a lesion on the transcribed strand of an
actively expressed genetic locus to impede
the progression of RNA polymerase is a
function ofseveral parameters-the stereo-
chemistry ofthe adduct, its inherent ability
to alter the processivity ofthe polymerase,
and the actual base incorporated into the
nascent RNA at or near the lesion-and
might be modulated by transcription
elongation factors.
Transcription-coupled
DNA Repair
TheRoleofCouplingFactors
An unsolved problem in the field ofDNA
repair concerns the composition of the
pathway that performs TCR once RNA
elongation is impeded by a lesion. Likewise,
a question ofgreat importance to the TCR
mechanism concerns the existence offactors
that might somehow sense a stalled tran-
scription complex, either causing the RNA
polymerase to dissociate, thus making the
adduct available for repair, or actually sum-
moning the repair machinery to the site of
damage, or both. In E. coli, a coupling
factor that links NER to TCR has been
identified; it is the product ofthe mutation
frequency decline (mfd) gene and is essen-
tial for TCR ofCPDs (41,42). This partic-
ular protein causes RNA polymerase to
dissociate, and it interacts with proteins
that are part of NER and draws them
toward the site ofdamage. Interestingly, the
Mfd protein contains helicase motifs, but it
is not a helicase.
In human cells, genetic loci that are
defective in Cockayne's Syndrome (CS)
encode proteins that are likelycandidates for
being TCR coupling factors. There are sev-
eral complementation groups for CS, two
unique ones referred to as A and B and
three which overlap with another repair
deficiency disease called xeroderma pigmen-
tosum (XP) (2,43). Cells derived from
patients with CS are hypersensitive to UV
irradiation, but repair ofCPDs does occur
in the genome overall (2,44). What is
absent from CS cells is the ability to perform
TCR (45). Two CS genes have been cloned;
one complements CS-A cells and one com-
plements CS-B cells (46,47). The CS-A and
CS-B proteins interact with one another;
additionally, the CS-A protein can bind
to p44 protein, a subunit of the human
RNA polymerase II transcription factor H
(TFIIH), suggesting that the CS gene
products might be involved in transcription.
CS is characterized by a significant lag time
in the recovery ofRNA synthesis following
exposure ofthe cells to certain genotoxins,
perhaps due to the slow removal ofadducts
from transcriptionally active regions. Hence,
the CS-A and CS-B proteins may act as
coupling factors for human TCR or might
effect changes in chromatin structure at sites
oftranscription, enabling these loci to be
betterrepaired (2,33,46,47).
While the identification of coupling
factors that link a stalled transcription com-
plex, DNA damage, and repair machinery
has been a great boon to understanding
TCR, the precise composition ofthe repair
pathway involved remains to be elucidated.
Indeed, the explicit nature ofthe pathway
that elicits TCR is not simple; it appears
to involve components of several repair
pathways in the cell, each ofwhich may
playa distinct role in the process.
TheRoleofNudeotide
Ecision Repair
Nucleotide excision repair is a repair
pathway that removes a wide variety of
DNA lesions from the genome; it appears
to recognize distortions in the double helix
and, therefore, possesses a broad specificity
for the types ofdamage that are cleared by
it (2,4,6). In E. coli, where NER is best
understood, the actual incision process at
the damaged site is a function ofthe prod-
ucts ofthe uvrA, uvrB, and uvrCgenes (6).
Recognition is accomplished by a protein
complex consisting ofa UvrA homodimer
associated with a UvrB monomer-
UvrA2-UvrB. Upon adduct recognition, the
UvrA proteins dissociate, and UvrC protein
binds, creating an exinuclease that incises
the damaged strand on either side of the
lesion such that during NER a roughly
12-base segment of DNA containing the
damage is removed. The product of the
uvrD gene, which is helicase II, is essential
for the removal of the damaged oligonu-
cleotide and turnover of the UvrB and
UvrC proteins (2,4,6).
Numerous mutant strains ofE coliexist
in which functional NER is absent. Such
uvrA-, uvrB-, and uvrC- cells have also
been used to investigate the role ofNER in
TCR in E. coli; in these strains, less than
10% ofthe CPDs were removed from each
strand ofthe lacZgene following exposure
to UV radiation, indicating that an intact
NER complex not only is required for the
general removal ofCPDs from these cells
but also is indispensable forTCR (48).
The clearance of UV-induced CPDs
from mammalian cells by NER is vastly
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more complex than the equivalent pathway
in E. coli; it is also less well understood. In
human cells, at least 30 gene products are
required for functional NER to occur; of
this number, 7 were identified partly by
studying cells derived from patients
afflicted with XP, which is characterized by
deficient NER and heightened sensitivity to
UV radiation (2,4,5,49). Individuals with
XP are prone to a variety ofpathological
conditions, including skin cancer and neu-
rological aberrations. The seven XP com-
plementation groups are labeled A through
G, and each exhibits a different phenotypic
sensitivity to UV light. For example, XP-A
cells do not repair CPDs and are very sensi-
tive to the lethal effects ofUV radiation; in
contrast, XP-C cells exhibit a modest level
ofdimer clearance and are less sensitive to
the detrimental effects of UV exposure
(49). A description of some of the genes
and the proteins involved in human NER
is summarized in Table 2; the function of
each is also listed when it is known.
TCR has been observed in mammalian
cells derived from both rodents and
humans, but the features ofthe process are
different in each case (14-16). In rodent
cells, the clearance of CPDs is manifested
as a high level of repair from the tran-
scribed strand of active genes, with virtu-
ally no clearance ofthese lesions from the
nontranscribed counterpart (16). In con-
trast, human cells exhibit repair in both
strands of active genes, albeit the rate of
repair is faster in the transcribed strand
(16). In terms ofTCR and its relationship
to NER, an important issue concerns
which of the particular gene products
responsible for NER are involved in biased
clearance of DNA lesions from human
cells. As mentioned, the severest form of
XP is manifested in complementation
group A. Cells derived from these patients
cannot repair CPDs found in the overall
Table 2. Genes and their products involved in NER in humE
genome; they also cannot perform TCR of
these adducts, indicating that recognition
by the XP-A protein ofthe actual CPD or
the helical distortion is necessary for the
transcription-coupled clearance of these
adducts (50,59).
Two ofthe gene products that take part
in NER, the XP-B and XP-D proteins, also
participate as elements of transcription
factor TFIIH in the cell and possess heli-
case activity (51,53,54,60). It is important
to understand that these two proteins play a
part in NER as part ofTFIIH (61). In other
words, TFIIH has a dual function in cells: It
acts as a transcription factor and as a com-
ponent ofNER, perhaps by interactingwith
different sets ofproteins in each case. XP-D
cells are slightly less sensitive to UV radia-
tion than XP-A cells, and they do remove
CPDs to a low but significant extent; how-
ever, TCRofthese lesions does not occur in
most XP-D mutant cells (2,49,59). This
suggests that the TFIIH factor is needed
for TCR by participating in NER to clear
the lesion; any additional role it plays in
the actual coupling process remains to be
established. The requirement for the XP-B
product in TCRhas not yet been evaluated
in a cell system, but assuming XP-D pro-
tein is involved in biased clearance of
adducts via its presence in TFIIH, it could
be predicted that XP-B would also be
involved. There is an important caveat
associated with the study ofTCR in XP-B
cells: All identified cases ofthis XP comple-
mentation group overlap with CS, which
could make the interpretation ofthe results
somewhat difficult (2).
The role of the XP-C protein in NER
and TCR is particularly intriguing. XP-C
cells are more resistant to the detrimental
effects ofUV radiation than XP-A, XP-B,
and XP-D cells; they also repair CPDs to
a small but significant extent (2,49).
Furthermore, the clearance of CPDs from
XPComplementation group Human genea Proposed protein function References
A XP-A DNAdamage recognition (50)
B XP-B/ERCC3 Helicase; part ofTFIH (51)
C XP-C Part oftranscription factors (52)
D XP-D/ERCC2 Helicase; part ofTFIH (53,54)
E Not cloned Binds damaged DNA (55)
F ERCC4 Nuclease (56)
G XP-G/ERCC5 Endonuclease activity (57)
aThe ERCCgenes were identified as those human genes that complemented NER defects in mutant rodent cells;
indeed, ERCC is an abbreviation for excision repair cross-complementing. The genes that are labeled as XP-A and
so on are those that were discovered by transfecting human DNA into cells belonging to differing XPcomplemen-
tation groups. There is also an ERCC1 gene whose product does not correct any of the XPphenotypes (58). A
thorough table describing these genes, their chromosomal locations, and rodent, yeast, and fly homologues can be
found in Friedberg et al. (2).
XP-C cells is limited to regions associated
with gene expression, suggesting that these
cells are capable of clearing damage from
expressed regions ofDNA but have limited
or no capability to clear the damage from
quiescent domains or heterochromatin
(62-64). Indeed, clearance ofCPDs from
the transcribed strand of active genes in
XP-C cells has been shown to occur (65).
The XP-Cgene has been cloned (52), but
the actual function ofthe XP-C protein is
not clear.
The role ofXP-E protein in NER and
TCR is not clear, but it does bind to
UV-damaged DNA (55). Of all the XP
complementation groups, XP-E cells are
the least sensitive to the lethal effects of
exposure to UV light (2,49). Whether or
not XP-E protein is essential or dispensable
during TCR of CPDs or other DNA
lesions is not known. Interestingly, XP-E
protein is not required for NER in a cell-
free system (2).
The XP-F protein, in association with
ERCC1, and XP-G protein are responsible
for incising the DNA on the 5' and 3' sides
ofthe lesion, respectively, causing the release
ofa roughly 29-base fragment ofDNA con-
taining the damage (2,4,6,56,57). TCR of
CPDs requires the XP-F product; however,
the need for XP-G protein has not yet been
examined (59). These results suggest that
the actual incision of the damaged DNA
during TCR of CPDs requires the same
endonucleolytic proteins used during NER
ofCPDs.
In summary, then, functional NER is
necessary for the TCR of CPDs in both
bacteria and mammalian cells. Furthermore,
studies concerning the specific repertoire of
NER proteins in human cells needed for
TCR indicate that XP-A, XP-D, and XP-F
gene products are required; the remaining
NER proteins might also be necessary, but
direct experimental data proving this asser-
tion are not yet available. Perhaps the most
curious of all the XP proteins in terms
ofTCR is the XP-C gene product; cells
that lack this gene product can perform
TCR but cannot execute general NER in
quiescent regions ofthe genome.
A final critical issue that needs to be
addressed in terms ofTCR is related to the
ability to clear chemical adducts in a biased
fashion via NER. As illustrated in Table 1,
numerous lesions other than those formed
following exposure to UV light are subject
to TCR. This poses a fundamental ques-
tion: Is the same set ofproteins needed to
clear CPDs via TCR also needed for the
biased removal ofalternate lesions such as
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those formed by exposure to ionizing radi-
ation or chemical compounds? While NER
is necessary for TCR of UV-induced
dimers, it might not be needed for the
biased clearance of all DNA adducts. For
example, it has been shown that TCR of
ionizing radiation-induced DNA damage
occurs in certain cells defective in NER as
well as in repair-proficient human cells;
this might be a function ofthe role ofBER
in TCR (22).
TheRole ofBaseExcision Repair
Another pathway responsible for removing
damage from DNA is BER. This mecha-
nism for clearing lesions involves the recog-
nition and removal ofcertain modified or
unmodified bases from the genome by
enzymes referred to as glycosylases. Their
mode ofaction involves removal ofthe tar-
get base as the initial step in its clearance
(2,7,8). Following removal of the target
moiety, subsequent action by an abasic
endonuclease, which may or may not be an
innate activity of the glycosylase itself,
cleaves the sugar phosphate backbone. The
nicked DNA that is generated is a substrate
for exonucleases, and repair is completed
by gap-filling by a DNA polymerase and
ligation ofthe newly synthesized DNA to
the contiguous DNA (2,7,8).
There are numerous examples of DNA
damage that is repaired by BER, two of
which include N-alkylpurines and thymine
glycols. The former are removed by 3-
alkyladenine-DNA glycosylase, and the
latter are cleared by thymine glycol-DNA
glycosylase (2,7,8). As mentioned, the sub-
sequent endonucleolytic cleavage is some-
times associated with the glycosylase
activity, as is the case for thymine glycol-
DNA glycosylase, or it can be independent
of the base removal step, as is true for
3-alkyladenine-DNA glycosylase. An
important issue concerning TCR is whether
glycosylase-mediated clearance of damage
exhibits a more rapid repair that is associ-
ated with the transcribed strand of active
genes. Evidence suggesting that this is the
case has been reported (22). It has been
shown that thymine glycols generated in
NER- and BER-proficient human cells
following exposure to ionizing radiation
are cleared in a biased fashion from the
transcribed strand of an expressed metal-
lothionein gene. Furthermore, TCR of
thymine glycols is still present in the same
locus in cells where BER is operating but
where NER is absent, suggesting that the
thymine glycol-DNA glycosylase is indeed
coupled to TCR.
The evidence that thymine glycol repair
is linked to TCR via BER leads directly to
consideration ofwhether such coupled
repair is found for other lesions that are nor-
mally cleared by BER. Experiments testing
for biased clearance of N-methylpurines
from the dihydrofolate reductase (dhfr)
gene of Chinese hamster ovary B11 cells
show no preferential clearance of these
adducts from the transcribed strand ofthis
locus regardless of the source of methyla-
tion damage (25,26,66). Furthermore,
when 7-methylguanine and 3-methylade-
nine repair rates are determined individu-
ally for each ofthe strands ofthe dhfrgene,
no TCR is observed in either case. This is
an important observation because 3-methy-
ladenine impedes transcription; hence, these
data indicate that an interruption to RNA
synthesis is not the sole factor responsible
for summoning TCR (26). Interestingly,
the clearance of N-ethylpurines shows a
strong bias toward the transcribed strand of
the dhfr gene in cells where NER is intact;
this preferential clearance is not seen in cells
lacking functional NER, where the observed
repair is presumably executed by BER.
These results indicate that BER is not cou-
pled to TCR, at least in the case ofethyl-
ated purines (Sitaram et al., unpublished
observations). Clearly, therewould be bene-
fits from investigating N-alkylpurine repair
in cells lacking the 3-alkyladenine-DNA
glycosylase; homozygous mutant mouse
cells have recently been characterized that
lack this activity, which now makes such
experiments feasible (67).
Several possible explanations for the
contrasting data concerning the preferen-
tial clearance of thymine glycols and
N-methylpurines by BER can be devised.
These two glycosylases are quite different,
not only in terms ofsubstrate recognition
but because thymine glycol-DNA glycosy-
lase actually contains an associated abasic
endonuclease activity, whereas 3-alkylade-
nine-DNA glycosylase does not possess
such a feature. There is the possibility that
the thymine glycol glycosylase is coupled
to transcription, but 3-alkyladenine-DNA
glycosylase is not part ofTCR. A second
possible source of the difference could lie
in the fact that thymine glycols are sub-
strates for both NER and BER in eukary-
otic cells, whereas N-methylpurines are
cleared primarilyby BER (6); however, this
does not account for the N-ethylpurine
data. A third viable explanation might be
that thymine glycols are blocks to transcrip-
tion, a fact that would make them subject
to TCR; in contrast, 7-methylguanines,
which constitute 80% of the N-methyl-
purines, do not appear to inhibit transcrip-
tion and would not be predicted to be
removed in a transcription-coupled fashion.
While the data concerning BER-
mediated TCR appear to be somewhat
contradictory, it is important to realize that
preferential DNA repair depends on several
factors: the type ofdamage, its location in
the genome, and its ability to block RNA
synthesis. A true understanding of the
TCR pathway can only be obtained by
considering the clearance of a variety of
different adducts from specific loci in cells
exhibiting different repair phenotypes.
Indeed, in a somewhat unexpected way,
the picture has been made even more com-
plex by the discovery that mismatch recog-
nition proteins comprise a pivotal element
ofTCR (48).
TheRoleofMismatchRepair
The genetics and biochemistry ofmethyl-
directed MMR have been extensively
characterized in E. coli (2,9,68). Single
base mispairs and small heteroduplexes
produced as a consequence ofinsertions or
deletions of a few nucleotides in one
strand of the duplex are corrected by this
repair system. Strand discrimination, mis-
match recognition, and incision require the
participation of at least three proteins-
MutS, MutL, and MutH. MutS binds het-
eroduplexes containing a mismatch, and
MutH recognizes hemimethylated GATC
sequences produced in newly replicated
DNA. While no specific biochemical activ-
ity has been assigned to MutL, a model
incorporating the roles of each of these
proteins in MMR has been proposed. The
coordinated action of MutS bound at a
mismatch and MutL protein activates
MutH endonuclease, resulting in the inci-
sion of the unmethylated strand near the
GATC sequence. Since the nearest GATC
sequence can be a considerable distance
from the mismatch, assembly ofthe inci-
sion complex may be facilitated by the for-
mation of a looped duplex to allow the
direct interaction of MutS and MutH. In
the presence of a preexisting nick in the
duplex, correction can proceed in the
absence ofMutH and a GATC sequence,
but MutS and MutL are still required. In
addition to methyl-directed MMR, MutS
and MutL also function in short patch
repair of G-T mispairs and the processing
ofrecombination intermediates.
The assortment ofmetabolic processes
in which mismatch repair proteins par-
ticipate was recently expanded to include
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TCR. This was first documented studying
the removal ofCPDs from the individual
strands ofthe induced lacoperon in certain
mutant strains of E. coli (48). Similar to
previous observations in repair-proficient
strains (31), CPDs were rapidly removed
from the transcribed strand, while repair in
the nontranscribed strand was much slower.
Repair in mutH- strains was virtually iden-
tical to repair in wild-type strains. In con-
trast, mutations in either the mutSor mutL
gene abolished the rapid repair ofthe tran-
scribed strand oflac, and both strands were
repaired at similar rates. These results were
similar to those obtained studying repair in
an mfdstrain but are markedly different
from repair in uvr- strains where no signif-
icant levels ofrepair in either strand ofthe
lac operon were detected. These results
suggest that in addition to Mfd and an
RNA polymerase complex, MutS, MutL,
and perhaps other factors are also involved
in the coupling ofNERand transcription.
The precise mechanism ofTCR and
the role ofmismatch repair proteins in the
process is unclear. Perhaps MutS and
MutL function by recognizing some fea-
ture of the RNA polymerase complex
stalled at a lesion or some structural distor-
tion associated with the transcription bub-
ble. The conformation ofthe DNA duplex
on each side ofthe arrested complex may
be altered, since transcription elongation
appears to affect the topology. The spec-
trum of DNA substrates recognized by
mismatch repair proteins has not been sys-
tematically tested. Some feature of the
transcription bubble or the surrounding
region might resemble a mismatched het-
eroduplex to which MutS binds and subse-
quently recruits MutL. Alternatively, MutS
might directly bind CPDs. After MutS and
MutL are recruited to the damaged site,
they may promote the formation of a
looped domain of DNA, similar to their
proposed roles in mismatch repair. After
the RNA polymerase complex is displaced
by Mfd, the lesion is available for recogni-
tion and incision by the UvrA, UvrB, and
UvrC proteins. In this model, recognition
ofthe lesion by Uvr proteins is enhanced as
a consequence ofthe altered DNAtopology
imposed bytranscription elongation.
The link between mismatch repair and
TCR could have important itnplications for
human disease. Mutations in the human
homologues ofthe E. coli mismatch repair
genes have been associated with a common
cancer predisposition syndrome, hereditary
nonpolyposis colorectal cancer (HNPCC),
and a subset ofsporadic cancers (69,70).
Recently, it has been demonstrated that
several MMR-deficient human tumor cell
lines and lymphoblastoid cell lines from
HNPCC patients are also defective in
TCR ofCPDs (71). Thus, the connection
between MMR and TCR first observed in
E. coli extends to humans; furthermore,
since mutations in MMR genes abolish
TCR, it is possible that exposure to car-
cinogens and a reduction in the repair of
environmentally induced damage con-
tribute to the development oftumors asso-
ciatedwith genetic defects in MMR.
The demonstration of a connection
between MMR and TCR of CPDs raises
several important questions: a) Are the
MMR proteins responsible for the coupling
ofNER to transcription? b) When BER is
coupled to transcription, does MMR play a
role in the process? and c) Do deficiencies
in TCR play a role in carcinogenesis? With
regard to the final question, it is important
to note that while cancer predisposition is
not associated with CS, these patients die at
veryearlyages.
A Model for Transcription-
coupled DNA Repair
Considering the complexity ofTCR and
the fact that the precise series ofevents that
executes it is not clear, it might seem fool-
ish to attempt to describe a model for the
process; however, such an exercise provides
a forum for addressing the issues that
remain unclear and for asking pertinent
questions. Figure 1 illustrates the funda-
mental steps ofTCR as it might occur in
humans and includes many ofthe compo-
nents described in the previous sections.
Following exposure to a genotoxic agent,
damage to genes might occur. When such
lesions are present in the noncoding-tran-
scribed-strand, RNA synthesis can be
impeded, provided that the actual adduct
has an effect on RNA polymerase elonga-
tion. An important issue at this juncture
concerns the effect of elongation factors
on the behavior of the polymerase at a
lesion; such factors might enhance bypass
of the adduct either by increasing the
RNA polymerase elongation rate or by
permitting it to back up and try again, as
is the case for TFIIS. Lesions that do not
impede the polymerase either innately or
because elongation factors assist in its
bypass would escape TCR. This is compli-
cated further by the fact that a subtle
structural detail such as adduct stereo-
chemistry can have a strong effect on the
lesion's ability to block RNA polymerase.
There is also the possibility that base
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Figure 1. Model for TCR. (A) The organism is exposed
to a genotoxin found inthe environment; the agent pro-
duces damage in the genome as represented bythe tri-
angle. (B) Initiation of transcription occurs, and RNA
polymerase (pol) enters elongation, using the noncod-
ing strand as a template. (C) When the damage is pre-
sent in the transcribed strand, it can decrease the
processivity of RNA polymerase. (D) The polymerase
can be stalled atthe site ofthe adduct, perhaps in part
by misincorporating an incorrect nucleotide, N, into the
transcript in the vicinity of the adduct present on the
noncoding strand. (E) The CS-AB proteins and the
MMR proteins cause the damaged region to act as a
better substrate for DNA repair pathways in the cell.
(F) BER or NER, depending on the type of damage,
removes the lesion, and following resynthesis of the
DNA and ligation, repair is complete.
misincorporation into the nascent tran-
script can facilitate pausing of RNA poly-
merase. In general, then, the first stage
required for TCR, stalling of the RNA
polymerase, is in and ofitselfaffected by a
complex array of factors, many ofwhich
still require further clarification of their
particular roles in the process.
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Once the RNA polymerase has stalled,
CS-A, CS-B, and mismatch recognition
proteins may enter the pathway. Precisely
how these factors interact with DNA at or
near the site ofdamage present on the tran-
scribed strand remains unclear. At least two
conceivable scenarios can be devised regard-
ing the role ofthese proteins in TCR, both
ofwhich rely on the notion that they some-
how convert the damaged site into a better
substrate for repair enzymes. One possibil-
ity is that the CS-A and CS-B factors first
displace the RNA polymerase in a manner
equivalent to that of the Mfd protein in
E. coli, making the lesion more available
for recognition by the MMR proteins; this
particular model relies on the prospect that
the recognition system for MMR can also
sense abnormal bases present in DNA, an
event that has been documented for sev-
eral DNA lesions (72,73). A second model
involves the possibility that interactions
among the CS-A, CS-B, and mismatch
proteins change the supercoiled nature of
the DNA at the adduct site, making the
region better for recognition by repair
proteins. Regardless of which of these
models is correct-in reality, both may be
proven to be incorrect-much biochem-
istry will need to be performed to test
these prospects.
The final step in TCR concerns the
precise nature ofthe repair pathway that
ultimately clears the damage; as of now,
either NER or BER participates in the
process. While NER, BER, and MMR have
been shown in part to effect TCR, the
potential role ofdirect reversal repair path-
ways has yet to be elucidated. With regard
to the repair machinery involved in TCR,
more studies concerning the clearance of
damage from cells with varying repair back-
grounds is essential, particularly as mutants
in BER become available. Also, the size of
the repair patch following the TCR of a
lesion from the transcribed strand of an
expressed gene has not been established;
hence no information concerning the
involvement of long-patch versus short-
patch repair can be used to support or refute
anyproposed mechanisms underlying TCR
Clearly, the general rules concerning TCR
will emerge fully only after studies address-
ingthese issues have been conducted.
It is clear that TCR operates on numer-
ous types of DNA damage that can be
induced in organisms by a wide range of
environmental agents; indeed, it is becom-
ing increasingly apparent that biased muta-
genesis within genes can occur following
exposure to chemicals and radiation, and it
maywell be a consequence ofTCR atwork
(2,3). Because mutations in the genome of
a cell can lead to transformation or death,
an understanding of mechanisms that
modulate cell formation of mutations is
critical for comprehending how environ-
mental carcinogens exert their toxic effects
on an organism.
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